Search clinical trials for: hereditary breast/ovarian cancer (BRCA1, BRCA2)
Total 88062 results
-
Data Collection Analysis Business ManagementPAS Research ServicesUnknownHereditary CancerUnited States
-
Institut Paoli-CalmettesUnknown
-
Lund UniversityCompletedHereditary Breast CancerSweden
-
University of UtahNational Cancer Institute (NCI)CompletedBreast Cancer | Ovarian Cancer | Genetic PredispositionUnited States
-
National Cancer Institute (NCI)CompletedBRCA1 Gene | BRCA2 GeneUnited States
-
Alexandru EniuIuliu Hatieganu University of Medicine and PharmacyCompletedTo Determine the Prevalence, Penetrance of BRCA1 and BRCA2 Mutations in Romanian Womens With Breast or Ovarian CancerRomania
-
Weill Medical College of Cornell UniversityBasser Research Center for BRCARecruiting
-
University of PennsylvaniaRecruiting
-
Memorial Sloan Kettering Cancer CenterUniversity of Pennsylvania; University of California, Los Angeles; Dana-Farber... and other collaboratorsActive, not recruiting
-
Azienda Ospedaliera Universitaria Policlinico Paolo...Unknown
-
National Human Genome Research Institute (NHGRI)Johns Hopkins Bloomberg School of Public HealthCompleted
-
Ohio State University Comprehensive Cancer CenterRecruitingBRCA1 Gene Mutation | BRCA2 Gene MutationUnited States
-
University of California, San FranciscoAmerican Cancer Society, Inc.CompletedBRCA1 Gene Mutation | BRCA2 Gene MutationUnited States
-
Rabin Medical CenterUnknownBRCA1 Gene Mutation | BRCA2 Gene MutationIsrael
-
European Institute of OncologyCompletedBRCA1 Mutation | BRCA2 Mutation | Psychosocial FactorsItaly
-
Priyanka SharmaBristol-Myers Squibb; Celgene CorporationActive, not recruitingBreast Cancer | Triple-Negative Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedAdult Solid Neoplasm | BRCA1 Mutation Carrier | BRCA2 Mutation CarrierUnited States
-
nVision MedicalCompletedBRCA1 Mutation | BRCA2 Mutation | Atypia Suspicious for MalignancyUnited States
-
University of WashingtonCompletedOvarian CancerUnited States
-
Okayama UniversityMerck Sharp & Dohme LLCRecruitingBreast Cancer | Breast Neoplasms | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | BRCA1 Mutation | BRCA2 Mutation | BRCA Mutation | BRCA-Associated Breast CarcinomaJapan
-
Dana-Farber Cancer InstituteWithdrawnOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Abramson Cancer Center at Penn MedicineRecruiting
-
Organisation for Oncology and Translational ResearchUnknown
-
PfizerMedivation, Inc.CompletedBreast Neoplasms | Small Cell Lung Carcinoma | Prostate Cancer | Ewing Sarcoma | Pancreas Cancer | Ovarian Cancer, Epithelial | Advanced or Recurrent Solid TumorsUnited States, United Kingdom
-
University Hospital, MontpellierCompleted
-
University of California, San FranciscoGlaxoSmithKlineRecruitingMetastatic Solid Tumor | BRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | ATM Gene MutationUnited States
-
University Hospital, GhentFox Chase Cancer Center; Ziekenhuis Oost-LimburgCompletedBRCA1 Mutation | BRCA2 Mutation | hCGBelgium
-
National Human Genome Research Institute (NHGRI)CompletedBreast CancerUnited States
-
UNICANCERCompletedLetrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation (LIBER)Breast Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2) | brca1 Mutation Carrier | brca2 Mutation CarrierFrance
-
Centre Hospitalier Universitaire de BesanconCompletedBreast Cancer | BRCA1 Mutation | BRCA2 MutationFrance
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Georgetown UniversityNational Cancer Institute (NCI); National Human Genome Research Institute (NHGRI)CompletedBreast Cancer | Ovarian CancerUnited States
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Istituto Oncologico di BariCompletedBreast Cancer | BRCA1 Mutation | BRCA2 Mutation | Dietary ModificationItaly
-
Weill Medical College of Cornell UniversityCompletedBreast Cancer | Gynecologic Cancer | BRCA1 Mutation | BRCA2 MutationUnited States
-
Rabin Medical CenterCompletedBRCA1 Gene Mutation | BRCA2 Gene MutationIsrael
-
Pamela MunsterNational Cancer Institute (NCI)Not yet recruitingBRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | ATM Gene Mutation | BRCA Mutation | Checkpoint Kinase 2 Gene MutationUnited States
-
Centre Oscar LambretCTD-CNO; Laboratoire PRISMActive, not recruitingBRCA1 Mutation | BRCA2 Mutation | Hereditary Breast and Ovarian CancerFrance
-
Memorial Sloan Kettering Cancer CenterYale University; Weill Medical College of Cornell University; New York Presbyterian...Recruiting
-
National Human Genome Research Institute (NHGRI)TerminatedBreast Cancer | Ovarian Neoplasm | Cancer GeneticsUnited States
-
Beth Israel Deaconess Medical CenterActive, not recruiting
-
Centre Francois BaclesseCompletedHereditary Breast and Ovarian Cancer SyndromeFrance
-
Memorial Sloan Kettering Cancer CenterUniversity of Washington; Sarah Lawrence CollegeCompletedBreast CancerUnited States
-
Translational Research Center for Medical Innovation...Okayama University; Japanese Gynecologic Oncology Group (JGOG)RecruitingFallopian Tube Carcinoma | Peritoneal Carcinoma | Ovarian Carcinoma | BRCA1 and/or BRCA2 Variant CarriersJapan
-
National Taiwan University HospitalUnknown
-
Mayo ClinicEnrolling by invitation
-
Stanford UniversitySusan G. Komen Breast Cancer Foundation; Breast Cancer Research FoundationRecruitingBreast Cancer | Ovarian Cancer | Gynecologic Cancers | Ovarian/Peritoneal/Fallopian CancerUnited States
-
Massachusetts General HospitalCompletedBreast Cancer | BRCA1 Mutation | BRCA2 MutationUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBreast Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited States
-
NYU Langone HealthWithdrawnBreast Cancer | BRCA1 Mutation | BRCA2 MutationUnited States
-
University of Alabama at BirminghamNational Cancer Institute (NCI)WithdrawnOvarian Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited States